Lobbying organisation

Eli Lilly Canada Inc.

21 meetings with public office holders, Oct 21, 2025 to Apr 14, 2026.

181 meetings on record since 2009, their first on record.

Meetings over time

  • Oct 2025: 6 meetings, with Peter Fragiskatos, Daryl Fridhandler, Ritu Banerjee, Rodrigo Arancibia, Matt Strauss
  • Nov 2025: 1 meeting, with Andrea Clements, Kaitlyn Pritchard, Wallace Ip
  • Dec 2025: 3 meetings, with Melanie Joly, Manuela Tomic, Brandan Rowe, Miro Froehlich, Ritu Banerjee
  • Jan 2026: 4 meetings, with Miro Froehlich, Brandan Rowe, Ritu Banerjee, Martin Moen, Loris Mirella
  • Feb 2026: 3 meetings, with Dominic LeBlanc, Karim Bardeesy, Janice Charette, Ritu Banerjee, Martin Moen
  • Mar 2026: 1 meeting, with Nasser Haidar
  • Apr 2026: 3 meetings, with Justine Frame, Maggie Chi, Paul Moen, Manuela Tomic, Karim Bardeesy
Oct 2025peak 6 in a monthApr 2026

Hover or focus a month to see who was met.

What they lobby about

The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.

Who they met

Conservative1 met · 1 meeting
Not in Arena's member list28 met · 44 meetings
  • Manuela Tomic
  • Miro Froehlich
  • Ritu Banerjee
  • Brandan Rowe
  • Rodrigo Arancibia
  • Justine Frame
  • Martin Moen
  • Nasser Haidar
  • Alexis Conrad
  • Andrea Clements
  • Brandan Rowe
  • Daniel MacDonald
  • Daryl Fridhandler
  • David Noris
  • Isabelle Mondou
  • Janice Charette
  • Jocelyne Voisin
  • Kaitlyn Pritchard
  • Loris Mirella
  • Miro Froehlich
  • Niloo Boroun
  • Patrick Blanar
  • Paul Moen
  • Philip Jennings
  • Sandenga Yeba
  • Sean Finnigan
  • Shalene Curtis-Micallef
  • Wallace Ip

Innovation, Science and Economic Development Canada (ISED) (15) · Privy Council Office (PCO) (9) · Global Affairs Canada (GAC) (8) · Health Canada (HC) (7) · House of Commons (7) · Intergovernmental Affairs Secretariat (IGA) (4)

In their own words

  • Free trade treaty agreement as it relates to the Canada/US Free Trade Agreement and free trade negotiations as it relates to Columbia, India, and the European Union.
  • The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
  • Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines.

Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.